Please assess the completion status of the following clinical trial:

Trial Title: Does Dehydro Epiandrosterone (DHEA) Improve Pregnancy Rate in Women Undergoing IVF/ICSI With Expected Poor Ovarian Response?

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women undergoing IVF/ICSI treatment with expected poor ovarian response according to the Bologna criteria~Exclusion Criteria:~* Women with BMI \>35 Kg/M2~* Women with a single ovary~* Known allergy to DHEA~* Diabetic women on insulin as insulin lowers DHEA levels and might reduce the effectiveness of DHEA supplements

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- DHEA (Type: ACTIVE_COMPARATOR): women will receive DHEA 6 weeks before starting IVF/ICSI
- Control (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).